United States · FDA National Drug Code directory

Sevelamer Carbonate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
65162-058_53f81fb7-7bbc-430f-a2e4-841b58e2cb7c
Product NDC
65162-058
Form
TABLET, FILM COATED
Composition / generic term
Sevelamer Carbonate
Labeler
Amneal Pharmaceuticals LLC
Marketing category
ANDA
Marketing start / end (source format)
20171128
Source listing expiry
20261231

Source-listed ingredients

  • SEVELAMER CARBONATE — 800 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (65162-058-03) · 65162-058-03
  • 60 TABLET, FILM COATED in 1 BOTTLE (65162-058-06) · 65162-058-06
  • 90 TABLET, FILM COATED in 1 BOTTLE (65162-058-09) · 65162-058-09
  • 1000 TABLET, FILM COATED in 1 BOTTLE (65162-058-11) · 65162-058-11
  • 270 TABLET, FILM COATED in 1 BOTTLE (65162-058-27) · 65162-058-27
  • 500 TABLET, FILM COATED in 1 BOTTLE (65162-058-50) · 65162-058-50

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →